This Ollie’s bargaining analyst is no longer optimistic. This is the top 5 relegation on Tuesday-NASDAQ: AMWD), AMPHASTAR PHARMA (NASDAQ: AMPH)

Top Wall Street analysts changed their views on these top names. Regarding the complete view of all analyst rating changes, including upgrading, downgrade and startup, please refer to our analysts’ rituals.

• Piper Sandler analyst David Amseellem David AMPHASTAR PHARMACEUTICALS, INCEssence Amph From overweight to neutrality, and the target target is reduced from $ 66 to $ 36. On Monday, AMPHASTAR PHARMA shares closed at $ 33.39. See how other analysts look at this stock.
• Baird analyst Peter Arment downgraded Triumph group, INCEssence TGI From running to everyone to neutrality, the target target has been raised from $ 20 to $ 26. Triumph Group stock closed at $ 25.10 Monday. See how other analysts look at this stock.
• Jefferies analyst Randal Konik reduced rating Ollie’s bargain Holdings, INCEssence OLLI From buying to holding, the target target is reduced from $ 125 to $ 111. On Monday, Ollie’s bargaining price was $ 107.63. See how other analysts look at this stock.
• UBS analyst MANAV GUPTA downgrade CALUMET, INCEssence CLMT From neutral to sale and targets from $ 20.5 to $ 15. Calumet shares closed at $ 18.34 on Monday. See how other analysts look at this stock.
• Wolf research analyst Trevor Allinson reduced rating American Woodmark AMWD From performance to peers. On Monday, Woodmark’s stock price closed at $ 75.65. See how other analysts look at this stock.

Consider buying OLLI stocks? Analysts believe: